ERElena Ros-Sánchez

Elena Ros-Sánchez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elena Ros-Sánchez has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prevalence of myopia and myopia trends among optometric telemedicine users in Spain: a retrospective nationwide observational study

    by Elena Ros-Sánchez, David Oliver-Gutiérrez, Sara García-Hidalgo, Marc Tort Lacambra, Ignacio Flores-Moreno, Jorge Ruiz-Medrano, Miguel Ángel Zapata Victori

    Purpose To evaluate the prevalence, severity, and temporal trends of myopia among patients attending optometric telemedicine screenings across Spain, and to describe age-specific distributions over time. Methods This retrospective, observational study analysed refractive data from 500,432 eyes of 269,868 patients evaluated at optometric centres nationwide in Spain within the UpRetina network between 2016 and 2024. Spherical equivalent (SE) values classified eyes into mild (SE ≤ − 0.50 D to − 3.00 D), moderate (–3.00 D to − 6.00 D), and high myopia (SE ≤ − 6.00 D). Both eyes were included when valid refractive data were available. Temporal trends were assessed by year and age. Descriptive and inferential statistics determined prevalence, SE distributions, and temporal changes. Results Among 500,432 eyes analysed, 104,497 (20.9%) were myopic. Of these, 60.1% were mild, 30.3% moderate, and 14.1% high myopia. Mean SE values were − 1.57 D (SD 0.68) for mild, − 4.18 D (SD 0.84) for moderate, and − 8.58 D (SD 2.92) for high myopia. High myopia was most prevalent in adults aged 20–40 years (16.2–16.9%). Mild myopia predominated in the youngest (< 10 years) and oldest (> 70 years) age groups. Temporal trends in myopia prevalence and severity were analysed across the study period (2016–2024) and stratified by age groups, revealing a slight increase in mild myopia (55.2% to 58.9%), stability in moderate myopia (28.9% to 28.7%), and a gradual decrease in high myopia (15.9% to 12.4%). Conclusions This nationwide study provides an updated overview of myopia prevalence and severity in Spain, highlighting a substantial burden, particularly of high myopia among young adults. Telemedicine in optometric centres offers a potential efficient approach for population-based screening, enabling early detection and targeted public health strategies to manage myopia and its complications.

  • Endogenous endophthalmitis in a tertiary referral centre: a 14-year case series with comparative perspective

    by Elena Ros-Sánchez, David Oliver-Gutiérrez, Rocío García-Risco, Liliana Gutuleac, Paul Buck, Tetiana Goncharova-Simon, Laura Distefano, Eric Kirkegaard-Biosca

    Purpose Endogenous endophthalmitis (EE) is a rare but severe ocular emergency caused by haematogenous spread of infectious microorganisms. This study analyses clinical characteristics, diagnostic challenges, microbiological spectrum, and treatment outcomes of EE cases over a 14-year period, comparing findings with published data. Methods A retrospective review was conducted on EE cases diagnosed at a tertiary care centre from 2010 to 2024. Data included demographics, clinical presentation, microbiology, diagnostics, treatment, and visual outcomes. Relevant literature was reviewed to contextualise findings and reflect on similarities and nuances in broader clinical experience. Results 27 patients with EE were identified. Systemic comorbidities, including malignancies and immunosuppression, were common. Ocular symptoms were present in 77% of cases, while 22% were asymptomatic. The majority exhibited unilateral involvement. Blood cultures (BC) were performed in 77% of cases, with a positivity rate of 66%. Vitreous biopsies were conducted in nine cases, yielding a 66% positivity rate. Treatment included systemic antibiotics or antifungals, topical medications, and intravitreal therapy (81% of cases). Pars plana vitrectomy (PPV) was performed in 51% of cases, though only two underwent early PPV. Final BCVA varied widely, with 59% of eyes achieving functional recovery. 21% of cases resulted in phthisis bulbi or evisceration, and 18% of patients died during follow-up due to systemic illness. Conclusion EE presents diagnostic and therapeutic challenges, with high risk of visual impairment and systemic morbidity. Early recognition, aggressive therapy, and timely surgery may improve outcomes. Further research is needed to establish standardised diagnostic and treatment guidelines for optimal management.


  • Early imaging and systemic findings in pediatric Vogt-Koyanagi-Harada disease

    by E. Ros-Sanchez, D. Oliver-Gutierrez, C. Parés-Alfonso, S. Alarcón Portabella, C. Wolley-Dod, N. Martín Begué

  • Open Access

    Multimodal imaging of tumour-related lipid exudation and exudative retinal detachment following brachytherapy in choroidal melanoma

    by Elena Ros-Sanchez, David Oliver-Gutierrez, Paul Buck, Tetiana Goncharova-Simón, Marta Garrido-Marín, Miguel Ángel Zapata-Victori, Anna Boixadera

    Choroidal melanoma is the most common primary intraocular malignancy, accounting for 90% of all uveal melanomas. Although radiation therapy (brachytherapy, proton beam and gamma knife) is a standard and effective treatment for choroidal melanomas, it carries a risk of vision-threatening complications such as cataract, optic neuropathy, and radiation retinopathy. A lesser-known complication is tumor-related lipid exudation (TRLE), characterized by subretinal and intraretinal lipid accumulation following radiotherapy, potentially resulting from radiation-induced vasculopathy and increased vascular permeability. We report a case of a 61-year-old man with a long-standing choroidal nevus under observation for 15 years. Due to signs of growth and subretinal fluid detected on OCT, malignancy was suspected, and Ruthenium-106 brachytherapy was performed. One-month post-treatment, the patient developed progressive exudative retinal detachment with lipid exudation, despite preserved visual acuity. At the nine-month follow-up, worsening exudation and tumor growth were observed, prompting a second brachytherapy session and intravitreal aflibercept injections every eight weeks, leading to complete resolution of lipid exudation and restoration of retinal anatomy. Six months post-treatment, the tumor remained flat, and visual acuity improved to 20/20. TRLE is an underrecognized complication of radiation therapy for choroidal melanoma, with risk factors including pre-radiotherapy subretinal fluid, increased tumour thickness, and Bruch’s membrane rupture. Studies suggest that anti-VEGF therapy may help mitigate exudative complications; however, its efficacy remains uncertain. This case highlights the importance of recognizing TRLE as a potential complication of brachytherapy and underscores the critical role of multimodal imaging in early diagnosis and monitoring, ensuring optimal treatment outcomes for patients with choroidal melanoma.

  • Choroidal macrovessel mimicking a choroidal mass: A diagnostic challenge

    by T. Goncharova, M. Tort, Y. Bertolani, P. Buck, D. Oliver-Gutiérrez, E. Ros-Sánchez, A. Pueyo, M. Garrido-Marin, A. Boixadera

  • Open Access

    Purpureocillium lilacinum-related endophthalmitis: case report

    by Elena Ros-Sánchez, David Oliver-Gutierrez, Paul Buck, Tetiana Goncharova, Laura Distefano, Eric Kirkegaard-Biosca

    Purpose: To report a case of Purpureocillium lilacinum endophthalmitis. Methods: The case of a fungal endophthalmitis caused by Purpureocillium lilacinum documented in an immunocompetent patient with no apparent trigger. Results: A 64-year-old male with a two-month history of panuveitis in his left eye was referred to our hospital. Initially misdiagnosed as sympathetic ophthalmia due to a previous surgery on his right eye 4 months before the onset of the left ocular picture, the patient received corticosteroid treatment, leading to a rapid deterioration of the left eye condition. An urgent exploratory vitrectomy was performed to identify the underlying cause, revealing endophthalmitis. Microbiological investigation yielded Purpureocillium lilacinum as the causative agent. Despite intensive treatment, including intravitreal antibiotics and antifungals, along with another surgical intervention, clinical evolution remained unfavourable, ultimately leading to the evisceration of the affected eye. Conclusions: Purpureocillium lilacinum poses a rare yet sever threat as a causative agent of fungal endophthalmitis. Managing such cases is challenging due to the delayed identification, fungus’s resistance to common antifungals, and its association with prior corticosteroid misuse in most patients. This case underscores the crucial importance of heightened clinical suspicion, early diagnosis, and the exploration of alternative treatment strategies in addressing Purpureocillium lilacinum endophthalmitis. The challenges posed by this rare fungal pathogen emphasize the need for a multidisciplinary approach and continued research to improve outcomes in these complex cases.